Anti-NMDAR encephalitis: demonstration of neuroinflammation and the effect of immunotherapy.

Abstract

A 35-year-old man presented with perceptual difficulties and delusions. At presentation, there were orofacial dyskinesias, catatonia, and autonomic instability. Anti–NMDA receptor (NMDAR) antibodies were detected in CSF. Cerebral MRI was unremarkable. At the start of immunotherapy (methylprednisolone and plasmapheresis), [I]CLINDE-SPECT demonstrated a strongly increased binding to TSPO in cortical and subcortical brain regions similar to the distribution of NMDAR in the brain and different from FDG-PET changes reported in the literature (figure, A). TSPO is present on activated microglia and used as a measure of regional neuroinflammation. After 7 weeks of immunotherapy (figure, B), TSPO binding was close to normal values (figure, C) and the patient was back to work part time as a computer scientist despite mild cognitive problems.

DOI: 10.1212/WNL.0000000000001278
0200400600201520162017
Citations per Year

339 Citations

Semantic Scholar estimates that this publication has 339 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Jensen2015AntiNMDARED, title={Anti-NMDAR encephalitis: demonstration of neuroinflammation and the effect of immunotherapy.}, author={Per F\oge Jensen and Daniel Kondziella and Gerda Thomsen and Agnete Dyssegaard and Claus Svarer and Lars H. Pinborg}, journal={Neurology}, year={2015}, volume={84 8}, pages={859} }